Bangladesh's measles toll moved faster than its inquiry.

On Thursday, the paper wrote that Dhaka had agreed to a probe while the toll stayed at 424. The point was not that the inquiry was meaningless. It was that a committee without named members, terms of reference or a deadline was still an announcement rather than an institution. Friday's reporting moves the death story forward while the roster remains absent.

The Business Standard now reports that measles mortality is surging outside Dhaka, with patients arriving late at hospitals and doctors calling for national treatment guidelines. [1] The same paper had reported the government's promise to form a committee with national experts and international organizations to investigate possible vaccine negligence. [2] Prothom Alo earlier recorded the health secretary saying an investigation was underway but not naming who was on it. [3]

The gap is no longer only procurement. It is clinical time. A vaccine delay creates the outbreak. A referral delay shapes who survives it. By the time a child reaches a tertiary hospital after days of fever, rash, pneumonia or dehydration, accountability is no longer a file in a ministry. It is oxygen, antibiotics, isolation, nutrition and the competence of a district system that was supposed to catch the child earlier.

That is why the story belongs in Life rather than politics. The political question remains sharp: who changed the procurement process, who ignored UNICEF's warning, who will sit on the committee, and whether the government will identify the decision chain behind the procurement process. But the new reporting is not only about blame. It is about the way an institutional failure travels through a child's body.

TBS's mortality account makes the outside-Dhaka pattern central. [1] Children are not simply dying because measles is circulating. They are dying after late referral, inconsistent management and the absence of a treatment protocol that pediatricians can apply across districts. That means the national campaign's headline coverage cannot settle the matter. Vaccinating millions now is essential, but it does not rescue children already exposed and medically fragile.

The probe announcement still matters because it is the only accountability mechanism on offer. The government said it would include international organizations and examine whether negligence in vaccine procurement and management contributed to the outbreak. [2] That phrasing is important. It acknowledges procurement and management in the same sentence. It also leaves the subject unspecified. Negligence by whom. Management by which office. Procurement under whose order.

Prothom Alo's earlier account noted that the health secretary did not answer questions about who was included in the investigation committee or when it had been formed. [3] That omission now carries more weight. A committee that exists only as a promise cannot interview district doctors, request purchase files, publish a mortality classification, or ask why children are arriving too late for ordinary care.

The divergence is familiar and still useful. Mainstream coverage has rightly followed the official mortality figures, campaign targets and expert warnings. X has treated the procurement decision as a coverup. The paper's contribution is to keep both halves in the same frame without letting either swallow the other. Procurement failure explains vulnerability. Referral failure explains deaths after vulnerability is established.

Bangladesh's public-health system is therefore facing two clocks. The first is the epidemic clock: infections, hospital admissions, deaths, vaccination coverage and the time it takes for immunity to build after a dose. The second is the accountability clock: committee roster, terms of reference, evidence list, report date. Friday's problem is that the first clock is visible and the second is not.

There is a cruelty in that mismatch. Parents experience the outbreak in hours. Officials answer it in committees. A child who is referred late does not care whether the committee includes WHO or UNICEF. But the next child might. Treatment guidelines, district triage and vaccine-supply restoration are institutional products. Someone has to write them, fund them and enforce them.

The government's strongest argument is that emergency vaccination has moved rapidly. That is true and insufficient. A campaign can be logistically impressive and still late. It can reduce the next wave while failing to explain the last one. It can show state capacity in May while exposing earlier state failure.

The missing names remain the tell. If the committee includes international experts with access to procurement documents, the inquiry becomes harder to bury. If it is staffed by ministry insiders, it becomes a political rinse. If it has no public deadline, it becomes a shelf. If it publishes district-level mortality and referral data, it becomes useful before it becomes punitive.

Friday's article is not an argument against the probe. It is an argument against treating the probe as proof of accountability before it has members. The death toll has moved. The clinical story has deepened. The committee still has not stepped onto the page.

-- PRIYA SHARMA, Delhi